Literature DB >> 21108531

Measuring the externality of antibacterial use from promoting antimicrobial resistance.

Klaus Kaier1, Uwe Frank.   

Abstract

BACKGROUND: The emergence and spread of antimicrobial resistance (AMR) has become a serious public health threat. Rational antibacterial policy, combined with enforcement of infection control practices are key strategies to combat AMR in the hospital setting. Loss of antibacterial activity as a direct result of antibacterial consumption can be modelled via the economic approach of a negative externality.
OBJECTIVE: To determine the externalities of antibacterial consumption and alcohol-based hand rub use for hand disinfection.
METHODS: A simple model was built, combining the results of a recently conducted cost-of-illness study with the results of a multivariate time-series analysis, which determined the impact of antibacterial consumption and alcohol-based hand rub use on the incidence of hospital-acquired infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
RESULTS: Consumption of a single defined daily dose of second-generation cephalosporins, third-generation cephalosporins, fluoroquinolones and lincosamides is associated with a negative externality of about €5, €15, €11 and €12, respectively. In contrast, use of 1 litre of alcohol-based hand rub solution for hand disinfection is associated with a positive externality of about €61. In other words, a single disinfection of the hands (use of 3 mL alcohol-based hand rub solution) saves an average €0.18 of the potential cost incurred by MRSA-related infections.
CONCLUSIONS: Quantifying the externalities of antibacterial use and alcohol-based hand rub use may lead to changes in prescribing behaviour and increase compliance with hand disinfection. Furthermore, the presented methodology of relating the cost of resistance to specific factors such as antibacterial use and hand disinfection provides information that may be useful for prioritizing prevention methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108531     DOI: 10.2165/11535640-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  23 in total

Review 1.  Cost-of-illness studies. Useful for health policy?

Authors:  M A Koopmanschap
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

Review 2.  Economic consequences of antimicrobial resistance.

Authors:  Joseph A Paladino; Jenna L Sunderlin; Connie S Price; Jerome J Schentag
Journal:  Surg Infect (Larchmt)       Date:  2002       Impact factor: 2.150

3.  An econometric view of the dynamic relationship between antibiotic consumption, hand disinfection and methicillin-resistant Staphylococcus aureus.

Authors:  Klaus Kaier; Uwe Frank
Journal:  J Antimicrob Chemother       Date:  2008-12-24       Impact factor: 5.790

4.  Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection.

Authors:  Klaus Kaier; Christian Hagist; Uwe Frank; Andreas Conrad; Elisabeth Meyer
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

5.  Bug/drug resistance. Sometimes less is more.

Authors:  C E Phelps
Journal:  Med Care       Date:  1989-02       Impact factor: 2.983

Review 6.  Community-acquired pneumonia.

Authors:  J G Bartlett; L M Mundy
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Estimating the cost of illness.

Authors:  D P Rice
Journal:  Am J Public Health Nations Health       Date:  1967-03

8.  Economic burden of adult pharyngitis: the payer's perspective.

Authors:  Alan R Salkind; Julie M Wright
Journal:  Value Health       Date:  2007-12-17       Impact factor: 5.725

9.  Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile.

Authors:  Nathalie Vernaz; Hugo Sax; Didier Pittet; Pascal Bonnabry; Jacques Schrenzel; Stephan Harbarth
Journal:  J Antimicrob Chemother       Date:  2008-05-08       Impact factor: 5.790

10.  Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.

Authors:  Dominique L Monnet; Fiona M MacKenzie; José Maria López-Lozano; Arielle Beyaert; Máximo Camacho; Rachel Wilson; David Stuart; Ian M Gould
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  5 in total

1.  Cost-Effectiveness of Surveillance for Bloodstream Infections for Sepsis Management in Low-Resource Settings.

Authors:  Erin C Penno; Sarah J Baird; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2015-07-14       Impact factor: 2.345

Review 2.  Applying evolutionary biology to address global challenges.

Authors:  Scott P Carroll; Peter Søgaard Jørgensen; Michael T Kinnison; Carl T Bergstrom; R Ford Denison; Peter Gluckman; Thomas B Smith; Sharon Y Strauss; Bruce E Tabashnik
Journal:  Science       Date:  2014-09-11       Impact factor: 47.728

3.  Anti-microbial Use in Animals: How to Assess the Trade-offs.

Authors:  J Rushton
Journal:  Zoonoses Public Health       Date:  2015-04       Impact factor: 2.702

Review 4.  How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations.

Authors:  Jenine R Leal; John Conly; Elizabeth Ann Henderson; Braden J Manns
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-02       Impact factor: 4.887

5.  Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.

Authors:  Poojan Shrestha; Ben S Cooper; Joanna Coast; Raymond Oppong; Nga Do Thi Thuy; Tuangrat Phodha; Olivier Celhay; Philippe J Guerin; Heiman Wertheim; Yoel Lubell
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-09       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.